Factor VII人Chromogenic Activity Assay试剂盒
Factor VII Activity Assay Kit (Human, Colorimetric)
Be the first to review this product! Submit a review
|
(3 Publications)
Factor VII Activity Assay Kit (Human, Colorimetric) (ab108830) has been developed to determine human FVII activity in plasma, serum and cell culture supernatants.
查看别名
Coagulation factor VII, Proconvertin, Serum prothrombin conversion accelerator, SPCA, F7
- FuncS
Supplier Data
Functional Studies - Factor VII Activity Assay Kit (Human, Colorimetric) (AB108830)
Representative Standard Curve for ab108830
- FuncS
Lab
Functional Studies - Factor VII Activity Assay Kit (Human, Colorimetric) (AB108830)
Factor VII measured in biological fluids showing quantity (IU) per mL of tested sample
反应性数据
产品详情
Factor VII Activity Assay Kit (Human, Colorimetric) (ab108830) has been developed to determine human FVII activity in plasma, serum and cell culture supernatants.
Factor VII assay principle
This assay uses a combined immunoassay / indirect amidolytic assay method.
A polyclonal antibody specific for Human FVII has been pre-coated onto a microplate and active FVII is bound to the immobilized antibody. The assay then measures the ability of lipoprotein TF/FVIIa to activate factor X (FX) to factor Xa.
The amidolytic activity of the TF/FVIIa complex is quantitated by the amount of FXa produced using a highly specific FXa substrate releasing a yellow para-nitroaniline (pNA) chromophore. The change in absorbance of the pNA at 405 nm is directly proportional to the FVII enzymatic activity.
Other Notes
This product was previously called Factor VII Human Chromogenic Activity Assay Kit.
Factor VII (FVII) is a vitamin K-dependent plasma glycoprotein that is synthesized in the liver and circulates in blood as a single-chain inactive zymogen with a molecular mass of 50 kDa. Upon tissue damage and vascular injury, the cell surface receptor and cofactor tissue factor (TF) binds and allosterically activates FVII to its active form, FVIIa. The TF/FVIIa complex catalyzes the conversion of both factor IX to factor IXa and factor X to factor Xa to initiate coagulation via the extrinsic pathway. Very low levels of FVII are associated with severe coagulation disorders. Elevated plasma levels of FVII coagulant activity constitute an independent risk factor for fatal outcomes of coronary heart disease in middle-aged men.
精确度
规格
性能和储存信息
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Factor 7a indirectly activates further components in the blood coagulation cascade. Upon activation factor 7a becomes a part of the tissue factor (TF) complex which includes tissue factor expressed on subendothelial cells. The complex triggers the activation of factor IX and factor X propagating the coagulation cascade downstream. This series of activations amplifies the signal for clot formation highlighting factor VII's integral role in initiating coagulation.
Pathways
Factor VII is primarily involved in the extrinsic pathway of the coagulation cascade. This pathway is initiated when factor 7a forms a complex with tissue factor a protein that becomes exposed at injury sites. Factor VII is also indirectly linked to the common coagulation pathway through activation of factor X. The interaction between these pathways ensures efficient and rapid clot formation. Additionally factor IX also interacts with factor VII in the intricate network of coagulation processes that sustain hemostasis.
靶点信息
文献 (3)
Recent publications for all applications. Explore the full list and refine your search
Iranian journal of parasitology 19:192-202 PubMed39011538
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 41:1480-1497.e9 PubMed37451272
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology research 6:671-684 PubMed29622581
2018
Applications
Biochemical assay
Species
Human
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com